Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Mier

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jun 14, 2022 6:45am

93 Views

Post# 34754245

RE:RE:RE:RE:RE:Mier

Heh ...we alL know wof fatS is mugsy. Not complicate. Indeed yesterday in this forum you said " I AM CONFUSED" and I said that I have benn telling you that you are confused for 2 Years. No issue we AGREE PERIOD. There many in this planet do not feel lonley

<< Previous

Bullboard Posts

Next >>

Critical materials crisis: Diversifying away from China’s monopoly